The complex structure of Gram-negative bacteria, protects them from various antibiotic treatments. These bacteria create ...

Race Oncology has achieved a breakthrough with its lead candidate RC220, uncovering the primary mechanism of action of its ...

PepsiCo, which also makes Doritos, Cap’n Crunch cereal, Funyuns and Mountain Dew, announced in April that it would accelerate ...

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...

If the U.S. stays on its current path, it will surrender its biotech lead not because China wins, but because Washington quits.

AbCellera (ABCL) has pivoted to in-house drug development, with two Phase 1 assets and a recent share price surge despite ...

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...

Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...

Trump and Greek CEO of Pfizer agree to cut US drug costs, launch a direct-to-consumer platform, and expand affordable access.

Discover Atai Life Sciences N.V.'s 275% YTD surge, driven by innovative psychedelic therapies for TRD. Click for my ATAI ...